Get the Stockscreener App
27.82
0.49%
0.1367
After Hours:
27.83
0.0077
+0.03%
Tema Oncology Etf stock is traded at $27.82, with a volume of 171.
It is up +0.49% in the last 24 hours and down -0.39% over the past month.
See More
Previous Close:
$27.69
Open:
$27.83
24h Volume:
171
Relative Volume:
0.06
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+3.43%
1M Performance:
-0.39%
6M Performance:
+5.15%
1Y Performance:
+19.92%
1-Day Range:
$27.82
$27.83
1-Week Range:
$27.00
$27.83
52-Week Range:
$23.73
$30.11
Tema Oncology Etf Stock (CANC) Company Profile
Name
Tema Oncology Etf
Sector
Industry
Phone
-
Address
-
Compare CANC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CANC
Tema Oncology Etf
|
27.82 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
299.86 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
602.55 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
605.07 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
260.51 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
509.74 | 124.43B | 0 | 0 | 0 | 0.00 |
Tema Oncology Etf Stock (CANC) Latest News
Disruptive Theme of the Week: Breakthroughs in Medicine - ETF Trends
(CANC) Investment Analysis - Stock Traders Daily
Pacer Data and Digital Revolution ETF (TRFK) Institutional Ownership 2024 - MarketBeat
(CANC) Technical Pivots with Risk Controls - Stock Traders Daily
7 Best-Performing Biotech ETFs for November 2024 - NerdWallet
The 5 Best Biotech ETFs of 2024 - TradingView
5 Small-cap Biotech ETFs to Watch (Updated 2024) - Investing News Network
(CANC) Trading Advice - Stock Traders Daily
Thrivent Financial for Lutherans Invests $8.62 Million in Tema Oncology ETF (NASDAQ:CANC) - Defense World
National Bankshares Cuts Lucero Energy (CVE:LOU) Price Target to C$0.75 - Defense World
(CANC) Technical Data - Stock Traders Daily
Tema Oncology ETF (NASDAQ:CANC) Short Interest Update - Defense World
Where are the Opportunities in (CANC) - Stock Traders Daily
Tema Oncology ETF (NASDAQ:CANC) Sees Large Decrease in Short Interest - Defense World
When the Price of (CANC) Talks, People Listen - Stock Traders Daily
Beyond Novo and Eli Lilly: Watch these biotech and weight loss drug names, fund manager says - CNBC
Tema American Reshoring ETF: Benefiting From The Return Of U.S. Manufacturing - Seeking Alpha
EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO - Quantisnow
5 Small-cap Biotech ETFs to Watch (Updated 2024) | INN - Investing News Network
Tema ETFs CIO on Investment Opportunities in Biotech - Opto RoW
How Big Pharma Is Taking A Page Out Of Novartis' Playbook - Investor's Business Daily
10 Best Performing Biotech ETFs in 2024 - Yahoo Finance
11 Best Biotech ETFs To Buy - Yahoo Finance
Healthcare ETFs for the Weight-Loss Drug Boom & Beyond - Yahoo Finance
Viking Therapeutics' weight-loss tablet shows promise in small study - ETHealthWorld
Is Gilead's 10% Crash — Resulting In A Failed Breakout — An Overreaction? - Investor's Business Daily
Sanofi CEO under pressure to woo investors after spending shock - Reuters.com
EXCLUSIVE: Tema ETFs' Innovative Thematic Investing Approach Targets New Opportunities Beyond The Fads - Markets Insider
Tema ETFs hops on weight-loss drug frenzy with its new cardiovascular fund - Reuters.com
12 Best Healthcare ETFs To Buy - Yahoo Finance
Investing in Oncology: A Biotech Revolution in Research, Diagnosis, and Treatment of Cancer - Nasdaq
Oncology Market's Huge Potential Puts These Stocks in Focus - Yahoo Finance
Royalties and cancer treatments: Thematic ETFs take new directions - InvestmentNews
How BlackRock’s Rick Rieder is steering his active fixed-income ETF as bond funds struggle - MarketWatch
This Week in ETFs: 2 Funds Launch From Tema - ETFdb.com
Thematic ETFs Struggle to Capture Financial Advisors’ Attention - etf.com
Tema launches three innovative, professionally managed thematic ETFs: American Reshoring, Luxury, & Monopolies and Oligopolies - Business Wire
Tema, Backed by Index, Accel and Zinal, Expands Access to Innovative Investment Themes Through Launch of Active ETF Platform - Business Wire
Ukroboronprom to Repair Captured Russian Tanks for Use by Ukrainian Army - Defense World
Pyxis Oncology (PYXS) Stock Price, News & Analysis - MarketBeat
Getting in on global luxury - ETF Strategy
Terns Pharmaceuticals (TERN) Stock Price, News & Analysis - MarketBeat
Relay Therapeutics (RLAY) Stock Price, News & Analysis - MarketBeat
Genmab A/S (GMAB) Stock Price, News & Analysis - MarketBeat
Arvinas (ARVN) Stock Price, News & AnalysisNASDAQ - MarketBeat
Cogent Biosciences (COGT) Stock Price, News & Analysis - MarketBeat
Exelixis (EXEL) Stock Price, News & AnalysisNASDAQ - MarketBeat
Tema Oncology Etf Stock (CANC) Financials Data
There is no financial data for Tema Oncology Etf (CANC). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.34%
Cap:
|
Volume (24h):